Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)

Clinical trial NCT03182907 · COMPLETED

Trial details

NCT number: NCT03182907
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2018-03-27
Primary completion: 2022-05-12
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.